Nutriomics and Artificial Intelligence Nutrition Obesity Cohort
Recruiting · NCT05494138 · Observational (researchers observe without assigning treatment) · Lead sponsor: Yonsei University
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study is to establish a prospective cohort. From registration to the 5th year, basic investigation, specific examinations for cardiovascular and metabolic disease, basic blood tests, collection of human material samples, and clinical event follow-up are conducted yearly. The obese group will be examined yearly, and telephone follow-up will be conducted if necessary. The control group will participate in the baseline survey once enrollment and clinical event follow-up by phone will be conducted annually thereafter. From the 6th year, only clinical event follow-up will be conducted.
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- for the obese group
- Adults 19 years of age or older
- Obese patients with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome (BMI ≥ 25 kg/m2, \[BMI ≥ 30 kg/m2, including 10% or more\])
- Inclusion criteria for the control group
- Adults 19 years of age or older
- Those with BMI 18.5\~24.9 kg/m2
Exclusion criteria
- for the obese group
- Serious non-cardiovascular disease with life expectancy less than 6 months
- Pregnant or suspected of being pregnant or are lactating
- Patients within 3 months of organ transplantation
- Patients currently being treated for acute transplant rejection
- Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and discharged within 6 months
- Patients with acute cerebral infarction within 6 months of being hospitalized and discharged
- Type 1 Diabetes
- Patients taking steroids, female hormones
- Those who have difficulty using smartphones
- Exclusion criteria for the control group
- Serious non-cardiovascular disease with life expectancy less than 6 months
- Pregnant or suspected of being pregnant or are lactating
- Persons who are continuously taking medications prescribed by a doctor due to chronic diseases excluding hypertension and dyslipidemia
- Within 5 years of diagnosis of malignant tumor
- Those who have difficulty using smartphones
Where it is running
1 location listed.
- Yonsei University Health System, Severance Hospital - Seoul, South Korea